A drug injected into the spinal fluid of Huntington’s disease sufferers has been found to lower levels of the protein which attacks the nervous system, a result which is “of ground-breaking importance,” says Professor Sarah Tabrizi (UCL Queen Square Institute of Neurology).
Read: Huffington Post, More: Yahoo! News
Close
